Nanalysis Scientific Corp. (NSCIF)
| Previous Close | 0.2950 |
| Open | 0.3000 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.3000 - 0.3000 |
| 52 Week Range | 0.2510 - 0.4950 |
| Volume | |
| Avg. Volume | 93,374 |
| Market Cap | 33.896M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1200 |
| Earnings Date | May 23, 2024 - May 27, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Simply Wall St.Nanalysis Scientific Full Year 2023 Earnings: CA$0.16 loss per share (vs CA$0.098 loss in FY 2022)
Nanalysis Scientific ( CVE:NSCI ) Full Year 2023 Results Key Financial Results Revenue: CA$28.5m (up 15% from FY 2022...
CNW GroupNanalysis Announces Fourth Quarter and Full Year 2023 Results
Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications announces fourth quarter and full year results for the period ending on December 31, 2023. Chief Executive Officer, Sean Krakiwsky and Chief Financial Officer, Randall McRae will host a conference call at 5 P.M. Eastern Time today to discuss the results. A second call will be held for European investors at 8:30am ET tomor
CNW Group/C O R R E C T I O N -- Nanalysis Scientific Corp./
Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications announces that on Monday, April 29th, 2024, the Company will put out a press release and Chief Executive Officer Sean Krakiwsky and Chief Financial Officer Randall McRae will host a conference call at 5:00 P.M. Eastern Time to discuss the results for the quarter and year ending December 31, 2023.
